![Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy - Urology Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy - Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7ef12ac3-ecb3-4453-9605-95a1797e2bab/gr1_lrg.jpg)
Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy - Urology
![Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase | Anticancer Research Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/4/1921/F2.large.jpg)
Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase | Anticancer Research
![Cancers | Free Full-Text | Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial | HTML Cancers | Free Full-Text | Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial | HTML](https://www.mdpi.com/cancers/cancers-13-01985/article_deploy/html/images/cancers-13-01985-g002.png)
Cancers | Free Full-Text | Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial | HTML
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
![IJMS | Free Full-Text | Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers IJMS | Free Full-Text | Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers](https://www.mdpi.com/ijms/ijms-17-01784/article_deploy/html/images/ijms-17-01784-g001-550.jpg)
IJMS | Free Full-Text | Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
![Beedrill SHADOWLESS PSA 8 (9000) #17 - Pokemon Graded Cards » Base Set Unlimited Shadowless - Graded Power Beedrill SHADOWLESS PSA 8 (9000) #17 - Pokemon Graded Cards » Base Set Unlimited Shadowless - Graded Power](https://d1rw89lz12ur5s.cloudfront.net/photo/gradedpower/file/0019bd2ff91f4551a2b2bc2c80f8ca90/DSC_6151.jpg)
Beedrill SHADOWLESS PSA 8 (9000) #17 - Pokemon Graded Cards » Base Set Unlimited Shadowless - Graded Power
![Obesity suppresses tumor attributable PSA, affecting risk categorization in: Endocrine-Related Cancer Volume 25 Issue 5 (2018) Obesity suppresses tumor attributable PSA, affecting risk categorization in: Endocrine-Related Cancer Volume 25 Issue 5 (2018)](https://erc.bioscientifica.com/view/journals/erc/25/5/images/ERC-17-0466fig2.jpeg)
Obesity suppresses tumor attributable PSA, affecting risk categorization in: Endocrine-Related Cancer Volume 25 Issue 5 (2018)
![The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-76786-9/MediaObjects/41598_2020_76786_Fig1_HTML.png)
The use of prostate specific antigen density to predict clinically significant prostate cancer | Scientific Reports
![A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening - European Urology A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2044998724/2056600602/gr1.jpg)
A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening - European Urology
![Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis | The BMJ Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis | The BMJ](https://www.bmj.com/content/bmj/362/bmj.k3519/F5.large.jpg)
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis | The BMJ
![Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice - ScienceDirect Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S228788821530060X-gr1.jpg)